BLRX
BioLineRX
BLRX
BLRX
29 hedge funds and large institutions have $6.69M invested in BioLineRX in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
97% less call options, than puts
Call options by funds: $13K | Put options by funds: $408K
Holders
29
Holding in Top 10
–
Calls
$13K
Puts
$408K
Top Buyers
| 1 | +$2.95M | |
| 2 | +$328K | |
| 3 | +$212K | |
| 4 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$210K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$118K |
Top Sellers
| 1 | -$888K | |
| 2 | -$168K | |
| 3 | -$47K | |
| 4 |
Millennium Management
New York
|
-$42K |
| 5 |
IP
Intellectus Partners
San Francisco,
California
|
-$32.8K |